• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov8
Novabay Pharmac released FY2025 Q3 earnings on November 7 (EST), actual revenue USD 521 K (forecast USD 3 M), actual EPS USD -0.2231 (forecast USD -0.21)
04:00
Novabay Pharmac released FY2025 9 Months earnings on November 7, 2025 (EST), actual revenue USD 521K, actual EPS USD 0.889
04:00
Aug19
NovaBay Pharmaceuticals Signs $6 Million Securities Purchase Agreement with David Lazar and Appoints Him CEO
21:52
Aug15
Novabay Pharmac released FY2025 Q2 earnings on August 14, 2025, EST: Actual Revenue USD 0 (Forecast USD 3 M), Actual EPS USD -0.3327 (Forecast USD -0.21)
03:00
Novabay Pharmac released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD 1.033
03:00
May16
Novabay Pharmac released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 0 (forecast USD 3 M), actual EPS USD 1.4449 (forecast USD -0.24)
03:00

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 521 K, Net Income -1.293 M, EPS -0.2231

Sep30
Distribution Plan(EST)

Cash dividend 0.8 USD

Sep29
Distribution Plan(EST)

Cash dividend 0.8 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More